Hhmi Bulletin
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Simon W.-L Chan Full CV
Simon W.-L. Chan University of California, Davis Department of Plant Biology 1 Shields Ave. Davis, CA 95616 (530) 754 9652 [email protected] Education and Research Experience July 2006- University of California, Davis, Davis, CA Assistant Professor 2002-2006 University of California, Los Angeles, Los Angeles, CA Postdoctoral fellowship Advisor: Dr. Steven E. Jacobsen 1996-2002 University of California, San Francisco, San Francisco, CA Ph.D. in Cell Biology. Advisor: Dr. Elizabeth H. Blackburn 1992-1995 University of Auckland, Auckland, New Zealand Bachelor of Science (with Honours) in Biochemistry. Advisor: Dr. Nigel P. Birch Awards 2010 Basil O’Connor Starter Scholar Award, March of Dimes 2006 American Society of Plant Biologists Early Career Award 2004 UCLA Boyer-Parvin Postdoctoral Award 2003-2006 Life Sciences Research Foundation Postdoctoral Fellowship (sponsored by the U.S. Department of Energy, Energy BioSciences division) 1997-2002 Howard Hughes Medical Institute Predoctoral Fellowship Advanced Coursework 2008 National Academies Education Fellow in the Life Sciences (attended The National Academies Summer Institute on Undergraduate Education in Biology). 2003 QB3 Microarray Course at UC Santa Cruz (taught by Dr. Joseph Derisi and colleagues). Publications Marimuthu, M.P.A.*, Jolivet, S.*, Ravi, M.*, Pereira, L., Davda, J.N., Cromer, L., Wang, L., Nogué, F., Chan, S.W.L.#, Siddiqi, I.# & Mercier, R.# Synthetic clonal reproduction through seeds Science in press * co-first authors, # corresponding authors Greenberg, M.V.C., Ausin, I., Chan, S.W.L, Cokus, S.J., Cuperus, J.T., Feng, S., Law, J.A., Chu, C., Pellegrini, M., Carrington, J.C. and Jacobsen, S.E. Identification of genes required for de novo DNA methylation in Arabidopsis Epigenetics 6, 344-354 (2011) Chan, S.W.L. -
Alex Greninger [email protected] 415-439-3448 Nominator Information
Nominee Information: Alex Greninger [email protected] 415-439-3448 Nominator Information: Keith Jerome [email protected] (206) 667-6793 Award: Young Investigator Award Statement of Recommendation January 5, 2017 To the selection committee: It gives me great pleasure to nominate Dr. Alex Greninger, a resident physician at the University of Washington, for an ASM/PASCV Young Investigator Award. Alex is an exceptional young scientist, and committed to a career in diagnostic virology. I hope I am able to convey the reasons behind my enthusiastic endorsement. Alex joined our laboratory 18 months ago, coming to us out of an MD/PhD program at UCSF, where he had worked with Drs. Joe DeRisi and Charles Chiu. Alex was remarkably productive during his graduate training, publishing approximately 40(!) papers in the peer-reviewed literature. His main focus was the use of unbiased technologies such as next-generation sequencing and mass spectrometry with an emphasis on viral illnesses. His first first-author paper detailed the discovery of salivirus, a new picornavirus that is associated with up to 4% of pediatric diarrhea. He then went on to perform an affinity purification mass-spectrometry screen of all culturable picornaviruses to find novel host protein interactors. This work culminated in the discovery of a new host protein ACBD3 that acts as a hub for PI4KB recruitment by a wide-array picornavirus 3A proteins, including the enteroviruses and rhinoviruses. Four years later, the crystal structures of these complexes are just being completed and forming the basis for the development of broadly-active 3A inhibitors against enteroviruses and other picornaviruses, similar to the NS5A inhibitors for hepatitis C virus. -
2019 Annual Report
BECKMAN CENTER 279 Campus Drive West Stanford, CA 94305 650.723.8423 Stanford University | Beckman Center 2019 Annual Report Annual 2019 | Beckman Center University Stanford beckman.stanford.edu 2019 ANNUAL REPORT ARNOLD AND MABEL BECKMAN CENTER FOR MOLECULAR AND GENETIC MEDICINE 30 Years of Innovation, Discovery, and Leadership in the Life Sciences CREDITS: Cover Design: Neil Murphy, Ghostdog Design Graphic Design: Jack Lem, AlphaGraphics Mountain View Photography: Justin Lewis Beckman Center Director Photo: Christine Baker, Lotus Pod Designs MESSAGE FROM THE DIRECTOR Dear Friends and Trustees, It has been 30 years since the Beckman Center for Molecular and Genetic Medicine at Stanford University School of Medicine opened its doors in 1989. The number of translational scientific discoveries and technological innovations derived from the center’s research labs over the course of the past three decades has been remarkable. Equally remarkable have been the number of scientific awards and honors, including Nobel prizes, received by Beckman faculty and the number of young scientists mentored by Beckman faculty who have gone on to prominent positions in academia, bio-technology and related fields. This year we include several featured articles on these accomplishments. In the field of translational medicine, these discoveries range from the causes of skin, bladder and other cancers, to the identification of human stem cells, from the design of new antifungals and antibiotics to the molecular underpinnings of autism, and from opioids for pain -
The US BRAIN Initiative
The US BRAIN Initiative Brain Research through Advancing Innovative Neurotechnologies John Donoghue, Ph.D. member US BRAIN Geneva Professor Advisory Commi5ee to the NIH Director of Neuroscience Director 1 views expressed here are my own and not those of the US Government Why a US BRAIN Initiative? The Need Is Great § Brain disorders: #1 source of disability in U.S. – > 100 million Americans affected § Rates are increasing § Costs are increasing- § annual cost of dementia ~$200B § by 2050 >$1Trillion § Already equals cost of cancer and heart disease The cost of disorders of the brain in Europe amounts overall to €798 billion in 2010 Eur Neuropsych. (2011) 21, 817-779 WHO, 2008 The Challenge for the 21st Century We do NOT know enough about the brain source: Donoghue! 3 “The Next Great American Project” “So there is this enormous mystery waiPng to be unlocked, and the BRAIN IniPave will change that by giving sciensts the tools they need to get a dynamic picture of the brain in acCon and be5er understand how we think and how we learn and how we remember. And that knowledge could be – will be – transformave.” -- President Obama, April 2, 2013 4 US BRAIN Initiative “a public and private effort” + Private Investments 5 The NIH BRAIN ScienCfic Plan • NIH Advisory Committee to the Director- William Newsome, PhD (co-chair) Working Group Stanford University (scientists, federal officials) • Met 2013-14 • Broad input from Cornelia Bargmann, PhD scientific community (co-chair) The Rockefeller University • Released June 2014 FIRST FIVE YEARS SECOND FIVE YEARS Emphasize technology Emphasize discovery development driven science 6 Understanding the Brain as a SYSTEM To map the circuits of the brain, measure the fluctuang paerns of electrical and chemical acPvity flowing within those circuits, and understand how their interplay creates our unique cogniPve and behavioral capabiliPes. -
ERNST SCHERING PRIZE 2021 for Pioneering Basic Research in Biology, Medicine and Chemistry
CALL FOR NOMINATIONS ERNST SCHERING PRIZE 2021 for pioneering basic research in biology, medicine and chemistry Awarded annually by the Schering Stiftung, Berlin, the 50,000-euro Ernst Schering Prize is one of the most prestigious German science awards honoring scientists worldwide whose research has pioneered fundamental breakthroughs in biomedicine. A particular focus is on researchers performing future-oriented top-level research and engaging in both scientific and public debates. INFORMATION ON THE PRIZE & THE NOMINATION PROCEDURE Prize money 50,000 EUR | There are no conditions attached to the prize money Nomination criteria • Eligible for application are individual scientists worldwide • who perform biological, medical or chemical research in the field of biomedicine, • whose pioneering research has in recent years resulted in new and inspiring avenues or led to breakthroughs in biomedical knowledge, and • who actively participate in relevant debates between science and society, or who have started initiatives to guide future generations and inspire them to further their career. A special focus is on nominees actively pursuing their scientific goals for the benefit of society. Nominations will be accepted from established scientists as well as from scientific societies or organizations. Submission deadline February 17, 2021 Nomination documents • Ernst Schering Prize nomination form (PDF on our website: www.scheringstiftung.de) • Brief summary of the research for which the nominee is nominated, explaining its significance and the -
Reviewers [PDF]
The Journal of Neuroscience, January 2013, 33(1) Acknowledgement For Reviewers 2012 The Editors depend heavily on outside reviewers in forming opinions about papers submitted to the Journal and would like to formally thank the following individuals for their help during the past year. Kjersti Aagaard Frederic Ambroggi Craig Atencio Izhar Bar-Gad Esther Aarts Céline Amiez Coleen Atkins Jose Bargas Michelle Aarts Bagrat Amirikian Lauren Atlas Steven Barger Lawrence Abbott Nurith Amitai David Attwell Cornelia Bargmann Brandon Abbs Yael Amitai Etienne Audinat Michael Barish Keiko Abe Martine Ammasari-Teule Anthony Auger Philip Barker Nobuhito Abe Katrin Amunts Vanessa Auld Neal Barmack Ted Abel Costas Anastassiou Jesús Avila Gilad Barnea Ute Abraham Beau Ances Karen Avraham Carol Barnes Wickliffe Abraham Richard Andersen Gautam Awatramani Steven Barnes Andrey Abramov Søren Andersen Edward Awh Sue Barnett Hermann Ackermann Adam Anderson Cenk Ayata Michael Barnett-Cowan David Adams Anne Anderson Anthony Azevedo Kevin Barnham Nii Addy Clare Anderson Rony Azouz Scott Barnham Arash Afraz Lucy Anderson Hiroko Baba Colin J. Barnstable Ariel Agmon Matthew Anderson Luiz Baccalá Scott Barnum Adan Aguirre Susan Anderson Stephen Baccus Ralf Baron Geoffrey Aguirre Anuska Andjelkovic Stephen A. Back Pascal Barone Ehud Ahissar Rodrigo Andrade Lars Bäckman Maureen Barr Alaa Ahmed Ole Andreassen Aldo Badiani Luis Barros James Aimone Michael Andres David Badre Andreas Bartels Cheryl Aine Michael Andresen Wolfgang Baehr David Bartés-Fas Michael Aitken Stephen Andrews Mathias Bähr Alison Barth Elias Aizenman Thomas Andrillon Bahador Bahrami Markus Barth Katerina Akassoglou Victor Anggono Richard Baines Simon Barthelme Schahram Akbarian Fabrice Ango Jaideep Bains Edward Bartlett Colin Akerman María Cecilia Angulo Wyeth Bair Timothy Bartness Huda Akil Laurent Aniksztejn Victoria Bajo-Lorenzana Marisa Bartolomei Michael Akins Lucio Annunziato David Baker Marlene Bartos Emre Aksay Daniel Ansari Harriet Baker Jason Bartz Kaat Alaerts Mark S. -
Viral Outbreak: the Science of Emerging Disease Lecture 4 – Solving SARS and Other Viral Mysteries Joe Derisi, Ph.D
Viral Outbreak: The Science of Emerging Disease Lecture 4 – Solving SARS and other Viral Mysteries Joe Derisi, Ph.D. 1. Begin of Lecture 4 (0:16) [ANNOUNCER:] From the Howard Hughes Medical Institute. The 2010 Holiday Lectures on Science. This year's lectures, "Viral Outbreak: The Science of Emerging Disease", will be given by Dr. Joseph DeRisi, Howard Hughes Medical Institute investigator at the University of California, San Francisco, and by Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley. The fourth lecture is titled Solving SARS and Other Viral Mysteries. And now to introduce our program, the President of the Howard Hughes Medical Institute, Dr. Robert Tjian 2. Welcome by HHMI President Dr. Robert Tjian (01:07) [DR. TJIAN:] Welcome back to this final presentation of this year's Holiday Lectures on Science. It's a great pleasure once again to introduce Joe DeRisi to give our fourth and last lecture in the series. Previously, Joe told us about how using bioengineering, computers, and molecular biology, he has been able to combine these tools for a potent approach to hunt for new viruses. In this lecture, Joe is going to show you how he can use his Virochip in real-time and in real life situations to discover and quickly diagnosis new viral outbreaks. Joe will also, I think, give us a glimpse of what the future in biotechnology holds towards the end of his talk. And now a brief video about Joe. 3. Profile of Dr. Joseph DeRisi (02:07) [DR. DERISI:] Science as we know it now is a highly interdisciplinary endeavor. -
3 and 4/1998 Genetic Engineering and Biotechnology
OCCASION This publication has been made available to the public on the occasion of the 50th anniversary of the United Nations Industrial Development Organisation. DISCLAIMER This document has been produced without formal United Nations editing. The designations employed and the presentation of the material in this document do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations Industrial Development Organization (UNIDO) concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries, or its economic system or degree of development. Designations such as “developed”, “industrialized” and “developing” are intended for statistical convenience and do not necessarily express a judgment about the stage reached by a particular country or area in the development process. Mention of firm names or commercial products does not constitute an endorsement by UNIDO. FAIR USE POLICY Any part of this publication may be quoted and referenced for educational and research purposes without additional permission from UNIDO. However, those who make use of quoting and referencing this publication are requested to follow the Fair Use Policy of giving due credit to UNIDO. CONTACT Please contact [email protected] for further information concerning UNIDO publications. For more information about UNIDO, please visit us at www.unido.org UNITED NATIONS INDUSTRIAL DEVELOPMENT ORGANIZATION Vienna International Centre, P.O. Box 300, 1400 Vienna, Austria Tel: (+43-1) 26026-0 · www.unido.org · [email protected] EMERGING TECHNOLOGY SERIES 3 and 4/1998 Genetic Engineering and Biotechnology UNITED NATIONS INDUSTRIAL DEVELOPMENT ORGANIZATION Vienna, 1999 TO OUR READERS EMERGING TECHNOLOGY SERIES: Globalization, the information society, sustainable development: these are the keywords of the day. -
CNIO FRONTIERS Meetings 2011 Recapturing Pluripotency: Links Between Cellular Reprogramming and Cancer
Spanish National Cancer Research Centre CNIO FRONTIERS Meetings 2011 Recapturing Pluripotency: links between cellular reprogramming and cancer 7-9 NOVEMBER 2011 Organisers: Maria A. Blasco CNIO, Madrid, Spain Konrad Hochedlinger Harvard University and Howard Hughes Medical Institute, Boston, USA Manuel Serrano CNIO, Madrid, Spain Inder Verma The Salk Institute, La Jolla, USA CNIO FRONTIERS Meetings 2011 Spanish National Cancer Research Centre Recapturing Pluripotency: links between cellular reprogramming and cancer 7-9 November 2011 2 Recapturing Pluripotency: links between cellular reprogramming and cancer CNIO FRONTIERS Meetings 2011 Summary 5 Detailed Programme 13 Session 1 21 Session 2 29 Session 3 39 Session 4 47 Session 5 55 Speakers’ Biographies 79 Poster session 101 CNIO Frontiers Meetings 2012 105 Previous CNIO Frontiers Meetings and CNIO Cancer Conferences Recapturing Pluripotency: CNIO FRONTIERS links between cellular Meetings 2011 reprogramming and cancer Detailed programme 5 CNIO FRONTIERS Meetings 2011 Detailed programme MONDAY, November 7th 09:30 Welcome Address Maria A. Blasco & Konrad Hochedlinger Session I: PLURIPOTENCY Chair: Rudolf Jaenisch 09:45 Rudolf Jaenisch, Whitehead Institute for Biomedical Research, Cambridge, USA Stem cells, pluripotency and nuclear reprogramming 10:20 Pablo Menéndez, GENyO (Pfizer-Universidad de Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Granada, Spain Short talk: Residual expression of ectopic reprogramming factors prevents differentiation of iPSCs generated -
Dynamics of Excitatory-Inhibitory Neuronal Networks With
I (X;Y) = S(X) - S(X|Y) in c ≈ p + N r V(t) = V 0 + ∫ dτZ 1(τ)I(t-τ) P(N) = 1 V= R I N! λ N e -λ www.cosyne.org R j = R = P( Ψ, υ) + Mγ (Ψ, υ) σ n D +∑ j n k D k n MAIN MEETING Salt Lake City, UT Feb 27 - Mar 2 ................................................................................................................................................................................................................. Program Summary Thursday, 27 February 4:00 pm Registration opens 5:30 pm Welcome reception 6:20 pm Opening remarks 6:30 pm Session 1: Keynote Invited speaker: Thomas Jessell 7:30 pm Poster Session I Friday, 28 February 7:30 am Breakfast 8:30 am Session 2: Circuits I: From wiring to function Invited speaker: Thomas Mrsic-Flogel; 3 accepted talks 10:30 am Session 3: Circuits II: Population recording Invited speaker: Elad Schneidman; 3 accepted talks 12:00 pm Lunch break 2:00 pm Session 4: Circuits III: Network models 5 accepted talks 3:45 pm Session 5: Navigation: From phenomenon to mechanism Invited speakers: Nachum Ulanovsky, Jeffrey Magee; 1 accepted talk 5:30 pm Dinner break 7:30 pm Poster Session II Saturday, 1 March 7:30 am Breakfast 8:30 am Session 6: Behavior I: Dissecting innate movement Invited speaker: Hopi Hoekstra; 3 accepted talks 10:30 am Session 7: Behavior II: Motor learning Invited speaker: Rui Costa; 2 accepted talks 11:45 am Lunch break 2:00 pm Session 8: Behavior III: Motor performance Invited speaker: John Krakauer; 2 accepted talks 3:45 pm Session 9: Reward: Learning and prediction Invited speaker: Yael -
As the Worm Turns with the Help of a Tiny Worm, Cornelia Bargmann Is Unpicking the Neural Circuits That Drive Eating, Socializing and Sex
NEWS FEATURE As the worm turns With the help of a tiny worm, Cornelia Bargmann is unpicking the neural circuits that drive eating, socializing and sex. BY STEPHEN S. HALL ale sexual dysfunction is never pretty, even in nematodes. every animal has to show and every animal has to solve?” she asks. “You In normal roundworm courtship, a slender male will sidle can basically say that the three would be hunger, fear and reproduction. up to a plump hermaphrodite, make contact, and then ini- None of those things got invented last Saturday night!” tiate a set of steps leading up to insemination: a sinuous The evolutionary strength of that argument grew last year, when Mbackwards motion as he searches for the sexual cleft, a pause to probe, Bargmann and her colleagues published the experiments with the and finally the transfer of sperm. The whole business is usually over in mutant males1. The mutation, they reported, is in a roundworm gene a couple of minutes. “It’s very slithery, and affectionate,” says Cornelia that they dubbed nematocin, which codes for a small peptide that influ- Bargmann, who has been observing the behaviour of this particular ences multiple neurons and is a biochemical cousin to oxytocin and vas- worm, Caenorhabditis elegans, for 25 years. opressin, two hormones that play key parts in mammalian reproductive Last October, scientists in Bargmann’s laboratory at the Rockefeller behaviour. Put another, Darwinian, way, the sexual confusion in mutant University, New York, reported the discovery of a gene that seems to be nematode males is tied to a molecule that seems to have been conserved crucial to successful mating. -
A Genetically Hard-Wired Metabolic Transcriptome in Plasmodium Falciparum Fails to Mount Protective Responses to Lethal Antifolates
A Genetically Hard-Wired Metabolic Transcriptome in Plasmodium falciparum Fails to Mount Protective Responses to Lethal Antifolates Karthikeyan Ganesan1.¤, Napawan Ponmee1,2,3., Lei Jiang1, Joseph W. Fowble1, John White1, Sumalee Kamchonwongpaisan3, Yongyuth Yuthavong3, Prapon Wilairat2, Pradipsinh K. Rathod1* 1 Department of Chemistry and Global Health, University of Washington, Seattle, Washington, United States of America, 2 Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok, Thailand, 3 National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Klong Luang, Pathumthani, Thailand Abstract Genome sequences of Plasmodium falciparum allow for global analysis of drug responses to antimalarial agents. It was of interest to learn how DNA microarrays may be used to study drug action in malaria parasites. In one large, tightly controlled study involving 123 microarray hybridizations between cDNA from isogenic drug-sensitive and drug-resistant parasites, a lethal antifolate (WR99210) failed to over-produce RNA for the genetically proven principal target, dihydrofolate reductase- thymidylate synthase (DHFR-TS). This transcriptional rigidity carried over to metabolically related RNA encoding folate and pyrimidine biosynthesis, as well as to the rest of the parasite genome. No genes were reproducibly up-regulated by more than 2-fold until 24 h after initial drug exposure, even though clonal viability decreased by 50% within 6 h. We predicted and showed that while the parasites do not mount protective transcriptional responses to antifolates in real time, P. falciparum cells transfected with human DHFR gene, and adapted to long-term WR99210 exposure, adjusted the hard-wired transcriptome itself to thrive in the presence of the drug.